Salus d.d.

Newsletters

TOPICS

COUNTRIES

INDUSTRY

LOGIN

Companies

Salus d.d.

Country

Slovenia

Industry

Wholesale/Retail

Owner

Individuals

Assets

67,616,846

Currency

EUR

Year

2024

Profit

10,874,033

Revenue

398,159

Employees

421

FULL COMPANY PROFILE

Latest news

Slovenia's Salus signs lecanemab distribution deal with Eisai EMEA

Jul 15, 2026

July 15 (SeeNews) - Slovenian pharmaceuticals distributor Salus said it has signed an agreement with the UK-based Europe, Middle Est and Africa (EMEA) hub of Tokyo-based pharmaceutical company Eisai for the distribution of lecanemab medication used for the treatment of Alzheimer's disease, across Slovenia, Croatia, Poland, Hungary and the Baltic states.

Slovenian stock market sets all-time highs in week ended July 10

Jul 13, 2026

Slovenian stock market gains ground in week ended June 5

Jun 9, 2026

Slovenia's Salus signs deal to buy Farmedica for 22 mln euro

Jun 5, 2026

Slovenia's Salus to distribute Oncopeptide’s Pepaxti drug in CEE

May 26, 2026

all stories about the company

more for country

more for top100

more for this industry

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.

About

SeeNews is your complete guide to the emerging economies of Southeast Europe. Latest news, market intelligence, industry analyses, on-demand research – the big picture at the tip of your fingers.

More about SeeNews

Premium access

Get ahead of the competition with SeeNews Premium Access. Unlimited news and objective analysis you can trust, company data and more. Subscribe now and start making agile business decisions.